

Gate Unveiling with Jordi Mata-Fink
Dec 5, 2023
Jordi Mata-Fink, co-founder of Gate Bioscience, discusses their work on commercializing a novel class of therapeutics called 'molecular gates' targeting extracellular proteins. He explores the power of platform-based problem-solving and team building in biotech startups, as well as the potential of small molecules to overcome therapeutic challenges. The episode also delves into the secretory translocon and the opportunities it presents for therapeutic intervention.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 3min
The Origin Story of Gate Bioccience and Molecular Gates
02:34 • 6min
The Secretory Translocon and Molecular Gates: Past, Present, and Future
08:56 • 12min
Building an Early Startup Team and the Importance of Complementary Skills
20:57 • 2min
The Power of a Platform and Building a Molecular Gate
23:21 • 5min